Dashboard
Manage Tickers

APTO Aptose Biosciences Inc


$ 0.01 (0.42 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 596.81 $ 9.47 (1.61 %)
DIA $ 465.38 $ 5.91 (1.29 %)
SPY $ 664.34 $ 9.34 (1.43 %)
TLT $ 89.38 $ -0.29 (-0.32 %)
GLD $ 376.13 $ 2.15 (0.57 %)
$ 1.69
-- x --
-- x --
-- - --
$ 0.64 - $ 11.69
1,438
na
na
$ 0.43
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nasdaq-surges-1-us-construction-spending-rises-in-february
Nasdaq Surges 1%; US Construction Spending...
04/01/2025 17:04:40

why-aptose-biosciences-apto-stock-is-down-over-40
Why Aptose Biosciences (APTO) Stock Is Dow...
04/01/2025 16:05:58

Aptose Biosciences shares are trading lower by 53.7% during Tuesday's session. The company announced it is going to delist ...

dow-dips-over-400-points-ism-manufacturing-pmi-falls-in-march
Dow Dips Over 400 Points; ISM Manufacturin...
04/01/2025 14:22:00

hc-wainwright--co-maintains-buy-on-aptose-biosciences-raises-price-target-to-6
HC Wainwright & Co. Maintains Buy on Aptos...
03/28/2025 17:47:21

HC Wainwright & Co. analyst Joseph Pantginis maintains Aptose Biosciences (NASDAQ:APTO) with a Buy and raises the price ...

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
02/26/2025 00:50:04

why-is-penny-stock-aptose-biosciences-trading-higher-on-thursday
Why Is Penny Stock Aptose Biosciences Trad...
02/20/2025 18:11:15

Aptose Biosciences advances its Phase 1/2 TUSCANY trial, escalating tuspetinib dosing after a favorable safety review. Enrollme...

aptose-announces-cohort-safety-review-committee-monitoring-phase-12-tuscany-trial-of-tusvenaza-unanimously-approved-escalating-from-40-mg-tus-to-80-mg-tus
Aptose Announces Cohort Safety Review Comm...
02/20/2025 12:33:29

why-global-blue-group-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why Global Blue Group Shares Are Trading H...
02/19/2025 12:00:50

us-stocks-likely-to-open-lower-following-fresh-records-from-previous-session-expert-says-dont-be-scared-of-new-highs
US Stocks Likely To Open Lower Following F...
02/19/2025 11:08:16

U.S. stock futures fell on Wednesday after scaling fresh records on Tuesday. The futures of all four benchmark indices were tra...

aptose-biosciences-plans-to-consolidate-common-shares-on-the-basis-of-1--for-30-reverse-share-split
Aptose Biosciences Plans To Consolidate Co...
02/18/2025 21:41:42

us-stocks-likely-to-open-higher-amid-ukraine-peace-talk-hopes-as-russian-american-officials-meet
US Stocks Likely To Open Higher Amid Ukrai...
02/18/2025 11:27:45

U.S. stock futures rose on Tuesday following a mixed close on Friday after the Presidents' Day holiday on Monday.

why-gcl-global-holdings-shares-are-trading-higher-by-around-107-here-are-20-stocks-moving-premarket
Why GCL Global Holdings Shares Are Trading...
02/18/2025 10:27:28

aptose-enters-25m-committed-equity-facility-and-enters-at-the-market-distributions
Aptose Enters $25M Committed Equity Facili...
02/13/2025 21:40:50

correction-hc-wainwright--co-reiterates-buy-on-aptose-biosciences-maintains-2-price-target-firm-name-change-from-rbc-to-hc-wainwright--co
CORRECTION: HC Wainwright & Co. Reiterates...
02/12/2025 16:58:23

CORRECTION:HC Wainwright & Co. analyst Joseph Pantginis reiterates Aptose Biosciences (NASDAQ:APTO) with a Buy and maintain...

rbc-capital-reiterates-buy-on-aptose-biosciences-maintains-2-price-target
RBC Capital Reiterates Buy on Aptose Biosc...
02/12/2025 16:52:33

RBC Capital analyst Joseph Pantginis reiterates Aptose Biosciences (NASDAQ:APTO) with a Buy and maintains $2 price target.

aptose-biosciences-reported-promising-early-safety-and-response-results-from-newly-diagnosed-aml-patients-in-the-phase-12-tuscany-trial
Aptose Biosciences Reported Promising Earl...
02/12/2025 12:08:06

aptose-reports-early-safety-and-response-results-in-phase-12-tuscany-trial-of-tuspetinib-in-combination-with-standard-of-care-dosing-of-venetoclax-and-azacitidine-says-tusvenaza-triplet-achieved-cycle-1-complete-remission-in-tp53-mutatedck-aml
Aptose Reports Early Safety And Response R...
02/12/2025 12:07:34

hc-wainwright--co-reiterates-buy-on-aptose-biosciences-maintains-2-price-target
HC Wainwright & Co. Reiterates Buy on Apto...
01/10/2025 12:17:56

HC Wainwright & Co. analyst Joseph Pantginis reiterates Aptose Biosciences (NASDAQ:APTO) with a Buy and maintains $2 pri...

aptose-announces-first-aml-patients-dosed-with-tuspetinib-triplet-frontline-therapy-in-tuscany-trial
Aptose Announces First AML Patients Dosed ...
01/09/2025 21:23:02

why-rumble-shares-are-trading-higher-by-around-43-here-are-20-stocks-moving-premarket
Why Rumble Shares Are Trading Higher By Ar...
12/23/2024 12:42:01

Shares of Rumble Inc.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION